1）海正生材 （上海季胜投资管理有限公司参与公司特定对象调研&电话会议） 调研纪要：3D打印行业进入快速发展期，聚乳酸作为重要原料，2024年消耗量预计超4万吨。海外企业 在3D打印领域聚乳酸供应中占据主导地位，国内企业占比不高，但公司凭借持续创新成为推动耗材升 级的重要力量。目前3D打印需求主要集中在欧美地区，国内需求起步晚但增速快。为提升市场份额， 公司将获取更多增量份额，服务头部企业，并加强研发和产品品质。3D耗材对聚乳酸性能有特殊要 求，如适应高速打印、快速冷却及不同颜色和视觉效果。聚乳酸市场供大于求，2024年全球消费量约26 万吨，国内约12万吨，价格已逼近成本线，未来波动不大。 机构简介： 根据市场公开信息及6月25日披露的机构调研信息，知名私募季胜投资近期对1家上市公司进行了调研， 相关名单如下： 季胜投资是专注于股票投资的投资机构，奉行价值投资基础上投机操作的理念。为客户的资产不断增值 为己任，追求每个季度都盈利是我们最高目标。xa0截止到2014年1季度末，已经连续超过10个季度保持 盈利。2013年正式阳光化，现为中国证劵业协会会员（编号：805151），中国证券投资基金协会基金管 理人 ...

Core Viewpoint - The company is responding to the Shanghai Stock Exchange's regulatory inquiry regarding the sale of a 25% stake in its subsidiary, Changyuan Electronics, which is valued at 3.4 billion yuan, below its assessed value of 15.163 billion yuan [1][10]. Valuation and Transaction Price - The valuation of Changyuan Electronics was conducted using the income approach, with the assessed value of 100% equity at 15.163 billion yuan, while the 25% stake is priced at 3.4 billion yuan, indicating a discount of 10.31% from the assessed value [1][12]. - The net assets of Changyuan Electronics increased from approximately 3.71 billion yuan in 2018 to about 11.96 billion yuan currently, reflecting a significant growth [1][10]. Financial Projections - The projected revenue for Changyuan Electronics from 2025 to 2029 is as follows: - 2025: 126.77 million yuan - 2026: 134.34 million yuan - 2027: 140.20 million yuan - 2028: 144.80 million yuan - 2029: 148.88 million yuan - The revenue growth rates are projected to decline from 6.84% in 2025 to 2.82% in 2029 [2][8]. Cost and Profitability - The total operating costs for Changyuan Electronics are projected as follows: - 2025: 90.45 million yuan - 2026: 97.12 million yuan - 2027: 102.52 million yuan - 2028: 106.73 million yuan - 2029: 110.34 million yuan - The gross profit margin is expected to decrease from 28.65% in 2025 to 25.89% in 2029 [3][9]. Cash Flow and Financial Health - The projected cash flows for Changyuan Electronics are as follows: - 2025: 9.16 million yuan - 2026: 9.49 million yuan - 2027: 9.78 million yuan - 2028: 9.91 million yuan - 2029: 9.83 million yuan - The cash flow growth rate is expected to decline from 3.66% in 2025 to -0.82% in 2029 [9][10]. Transaction Rationale - The sale of the 25% stake is aimed at improving liquidity and optimizing the asset structure of the company, as the subsidiary has not provided significant dividends to the parent company [14][17]. - The company has faced financial challenges, including a reported loss of 9.78 billion yuan in 2024, necessitating the sale to repay bank loans and supplement operational funds [18]

Group 1 - The core viewpoint of the document is the legal opinion regarding the adjustment and initial grant of the 2025 restricted stock incentive plan for Shanghai Narl Industrial Co., Ltd. [2][17] - The adjustment of the incentive plan includes a reduction in the total number of granted rights from 5.875 million shares to 5.645 million shares and a decrease in the number of initial grantees from 120 to 115 [7][8] - The initial grant of restricted stock is set for June 25, 2025, with a total of 4.645 million shares to be granted to eligible participants [12][13] Group 2 - The granting price of the restricted stock has been adjusted from 4.79 RMB per share to 4.67 RMB per share [11] - The company has fulfilled necessary approval and authorization procedures for the adjustments and grants, complying with relevant laws and regulations [17] - The conditions for granting the restricted stock include the absence of negative audit opinions and compliance with the regulations set forth in the incentive plan [14][15]

Group 1: Core Business and Financial Performance - The core business of the company includes energy chemical and chemical logistics sectors, focusing on the manufacturing of chemical raw materials and products, as well as chemical logistics [1] - In Q1 2025, the company achieved a revenue of 6.206 billion yuan, representing a year-on-year growth of 19.39%, and a net profit attributable to shareholders of 946 million yuan, up 26.26% year-on-year [1] - As of March 31, 2025, the total assets of the company amounted to 43.3 billion yuan, an increase of 1.11% from the beginning of the year, while the equity attributable to shareholders rose by 3.83% to 28.281 billion yuan [1] Group 2: Digitalization and Technological Innovation - The company is focusing on digitalization and intelligentization to enhance process management and drive production innovation, which has become a consensus in the industry [3] - In 2024, the company identified "digitalization and intelligentization" as a key strategy for building new advantages, collaborating deeply with Huawei to create a comprehensive digital application and innovation model [3] - The goal is to develop a one-stop smart platform that integrates visualization, statistical analysis, early warning monitoring, predictive analytics, data quality management, and intelligent decision-making [3] Group 3: Research and Development - In 2024, the company's R&D investment reached 665 million yuan, accounting for 2.64% of sales revenue, with a workforce of 1,031 technology personnel [4] - As of December 31, 2024, the company held a total of 420 patents, including 45 invention patents, 374 utility model patents, and 1 design patent [4] - These achievements demonstrate the company's strong resilience and commitment to high-quality development, maintaining a high level of R&D investment and enhancing its role as a practitioner of innovation-driven development in the industry [4]

Core Viewpoint - The company is utilizing temporarily idle raised funds for cash management to enhance fund efficiency and generate investment returns without affecting normal operations and maintaining risk control [1][2][10]. Summary by Sections Cash Management Overview - The purpose of cash management is to maximize the use of temporarily idle raised funds while ensuring normal operations and risk control [2]. - The funds used for cash management are sourced entirely from temporarily idle raised funds, specifically from the 2014 non-public stock issuance and the 2018 asset acquisition fundraising [2][3]. Fundraising Details - The total amount raised from the 2014 non-public stock issuance was 62,865 million, with a remaining balance of 30,956,300 as of June 25, 2025 [5]. - The 2018 asset acquisition fundraising had a total investment of 100 million, with a remaining balance of 133,800 as of June 25, 2025 [5][6]. Cash Management Products - The company has engaged China Minsheng Bank to manage cash through structured deposits, with two products totaling 2,488 million [4][5]. - The first product has an expected annual yield of 0.9%-1.6% and a term of 32 days, while the second product has an expected yield of 0.95%-1.65% and a term of 61 days [5][7]. Risk Control Measures - The company has established internal controls to ensure the safety of funds during cash management, including separation of decision-making, execution, and supervision [8]. - The cash management products are low-risk, with a commitment to capital protection, and the company will maintain close contact with the bank to monitor the investment [8][9]. Financial Impact - The cash management initiative is expected to improve fund efficiency and generate returns without adversely affecting the company's main business or fundraising projects [10]. - As of March 31, 2025, the company's cash management payments totaled 2,488 million, representing 2.88% of the total cash [10][11]. Recent Cash Management Performance - In the last 12 months, the company invested 45,138 million in cash management products, with actual returns of 264.88 million [13]. - The highest single-day investment in the last year was 10,470 million, which is 3.61% of the net assets [13].

Summary of Key Points Core Viewpoint - Shanxi Tongde Chemical Co., Ltd. has provided guarantees totaling RMB 149.15 million for its subsidiaries, which represents 74.70% of the company's latest audited net assets. The company has recently signed a guarantee contract with China Bank for a loan of RMB 9.5 million for its wholly-owned subsidiary, Xinzhou Tongli Blasting Engineering Co., Ltd. [1][2][5] Guarantee Overview - The company has approved a total guarantee amount not exceeding RMB 3 billion for its wholly-owned and controlling subsidiaries [1][2] - Prior to the recent guarantee, the total guarantee balance was RMB 146.25 million, which increased to RMB 147.20 million after the new guarantee [2] Subsidiary Information - The guaranteed entity, Xinzhou Tongli Blasting Engineering Co., Ltd., has total assets of RMB 82.92 million and liabilities of RMB 23.54 million as of December 31, 2024. The company reported a net profit of -RMB 1.79 million for the same period [2][3] Guarantee Agreement Details - The guarantee agreement specifies that the company will be liable for the principal, interest, penalties, and other costs associated with the debt if the subsidiary defaults [3][4] - The guarantee period lasts for three years after the main debt is settled, or until the last installment is paid if the debt is to be repaid in installments [4] Cumulative Guarantee Amount - The total guarantee amount provided by the company and its subsidiaries is RMB 3 billion, with an actual guarantee balance of RMB 147.20 million, accounting for 73.72% of the latest audited net assets [5]

文/梧桐数据中心 6月23日至6月24日，深、北交易所又新受理了19家IPO。其中深交所主板新受理1家：福恩股份，创业板新受理4家：贝特利、联亚药业、欣兴 工具、高特电子；北交所新受理14家：南方乳业、中健康桥、康美特、海昌智能、德硕科技、弥富科技、新纳科技、中德科技、斯瑞达、北 方实验、欧伦电气、广泰真空、天康制药、传美讯。 截至6月24日，2025年沪、深、北三大交易所共受理了80家IPO项目，其中上交所受理了14家、深交所受理了17家、北交所受理了49家。 一、杭州福恩股份有限公司深主板IPO，6月24日获受理 公司前身有限公司成立于1997年1月22日，2023年9月1日整体变更为股份公司。公司目前注册资本17,500万元。 （一）主营业务 公司是一家以可持续发展为核心的全球生态环保面料供应商，以生态环保面料的研发、生产和销售作为主营业务。公司的主要产品为生态环 保面料，以再生面料为主。 （二）控股股东、实际控制人 湃亚控股持有公司6,400万股股份，持股比例为36.57%，为公司控股股东。公司的实际控制人为王内利、王学林和王恩伟，王内利、王学林系 夫妻关系，王内利、王恩伟系父女关系。王内利、王学林和 ...

瑞财经 钟鸣辰近日，晨光新材(SH605399)发布2025年一季报。 | | | | 单位:元 币种:人民币 | | --- | --- | --- | --- | | 项目 | 本报告期 | | 本报告期比上年同 | | | | 上年同期 | 期增减变动幅度 | | | | | (%) | | 营业收入 | 232,521,752,26 | 273,853,534.36 | -15.09 | | 归属于上市公司股东的净利 | -4,730,216.63 | 25,646,683.60 | -118.44 | | 润 | | | | | 归属于上市公司股东的扣除 | -11,794,087.83 | 15,169,774.42 | -177.75 | | 非经常性损益的净利润 | | | | | 经营活动产生的现金流量净 | -16,362,217.94 | -5,834,283.11 | 不适用 | | 额 | | | | | 基本每股收益(元/股) | -0.02 | 0.08 | -125.00 | 报告显示，晨光新材公司一季度营业收入为2.33亿元，同比下降15.09%；归母净利润为-473.02万 ...

小财米 上周（2025年6月16日至6月22日）根据上海证券交易所、深圳证券交易所、北京证券交易所发布的信息显示，共有三家企业撤回IPO首发申请材料。其中， 沪市主板1家，深市主板1家，北交所1家。 | 板块 | 企业名称 | 注册地 | 行业 | | --- | --- | --- | --- | | 上交所 | 主板 青岛海湾化学股份有限公司 | 山东 | 化学原料和化学制品 | | 深交所 | 主板 浙江晴天太阳能科技股份有限公司 | 浙江 | 专业技术服务业 | | 北交所 | 北京兆信信息技术股份有限公司 | 北京 | 软件和信息技术服务 | 青岛海湾化学股份有限公司 海湾化学主营业务为氯碱化工、有机化工原料和高分子新材料以及无机硅产品的研发、生产与销售，主要产品包括乙烯法PVC、苯乙烯、聚苯乙烯3以及烧 碱，同时利用部分自产烧碱生产偏硅酸钠，实现对无机化学品业务的延伸。 | 项目 | 2022年6月30日 | 2021 年 12月 31 日 | 2020年12月31日 | | --- | --- | --- | --- | | | /2022 年 1-6 月 | /2021 年度 | /2020 ...

Group 1 - The core point of the article is that Xingye Co., Ltd. is currently in the sample testing phase for its phenolic resin business used in semiconductor photoresists, and has not yet signed any supply contracts [1] - The company's stock has experienced a significant price fluctuation, with a cumulative increase of 20% over three consecutive trading days, which is classified as an abnormal trading situation [1] - The company confirms that its production and operations are normal and that there are no major events affecting the abnormal stock price fluctuations [1] Group 2 - The phenolic resin business related to semiconductor photoresists has not generated any sales revenue yet, and its future progress remains uncertain [1] - The company has stated that it does not have any undisclosed major information that should be disclosed [1]